Caligan Partners as of March 31, 2023
Portfolio Holdings for Caligan Partners
Caligan Partners holds 11 positions in its portfolio as reported in the March 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Liquidia Corp Com New (LQDA) | 44.6 | $64M | 9.2M | 6.91 | |
| Anika Therapeutics (ANIK) | 14.3 | $21M | 715k | 28.72 | |
| D Fluidigm Corp Del (LAB) | 11.7 | $17M | 8.6M | 1.95 | |
| Exelixis (EXEL) | 11.5 | $17M | 850k | 19.41 | |
| Evolus (EOLS) | 9.0 | $13M | 1.5M | 8.46 | |
| Adma Biologics (ADMA) | 3.8 | $5.5M | 1.7M | 3.31 | |
| Verona Pharma Sponsored Ads (VRNA) | 2.6 | $3.7M | 183k | 20.08 | |
| Recro Pharma | 0.9 | $1.3M | 1.1M | 1.19 | |
| Eyepoint Pharmaceuticals Com New (EYPT) | 0.9 | $1.3M | 435k | 2.94 | |
| Alimera Sciences Com New | 0.7 | $1.0M | 479k | 2.10 | |
| Agios Pharmaceuticals (AGIO) | 0.1 | $100k | 4.3k | 22.97 |
